SCHEMBL22164115

SCHEMBL22164115

FC(F)(F)c1cc(CNc2ccc3ccccc3n2)ccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
HDAC6 Q9UBN7 1/20 0.48
USP1 O94782 6/20 0.47
WDR48 Q8TAF3 6/20 0.47
KDM4E B2RXH2 1/20 0.45
TP53 P04637 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MCHR1 Q99705 1/20 0.44
AURKA O14965 3/20 0.42
RPS6KB1 P23443 3/20 0.42
TRPV1 Q8NER1 2/20 0.42
AURKB Q96GD4 1/20 0.42
IDO1 P14902 2/20 0.42
P2RX7 Q99572 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22164114 0.84 USP1 (0.41) USP1WDR48TP53MCHR1AURKA
SCHEMBL28220529 0.79 HDAC6 (0.61) NPC1RAB9AHDAC6USP1WDR48
SCHEMBL14980555 0.77 NPC1 (0.63) NPC1RAB9AHDAC6KDM4ETP53
SCHEMBL12175974 0.74 RAD52 (0.64) USP1WDR48KDM4E
SCHEMBL9921367 0.73 AURKA (0.63) RAB9AUSP1WDR48HTTSMN1; SMN2
SCHEMBL19553834 0.73 RAB9A (0.66) NPC1RAB9AHDAC6KDM4ETP53
SCHEMBL30885179 0.73 RAB9A (0.66) NPC1RAB9AHDAC6KDM4ETP53
SCHEMBL6774198 0.72 MARS1 (0.49) NPC1RAB9AHDAC6KDM4ETP53
SCHEMBL22926769 0.71 NPC1 (0.63) NPC1RAB9AHDAC6KDM4ETP53
SCHEMBL6089806 0.70 HDAC6 (0.54) NPC1RAB9AHDAC6KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020136693-A1 SUBSTITUTED QUINOLONE COMPOUNDS, THEIR USE IN THE TREATMENT OF CANCER, AND A METHOD FOR PREPARATION UNIVERSITY OF PETRA (JO) 2020-07-02 WO disclosed